EFFECT OF PENTAZOCINE ON EHRLICH ASCITES TUMOR CELLS
スポンサーリンク
概要
- 論文の詳細を見る
The effect of pentazocine, a non-narcotic analgesic, on Ehrlich ascites tumor cells was examined <I>in vitro</I> and <I>in vivo</I>. To test the <I>in vitro</I> effect of pentazocine, Ehrlich tumor cells suspended in Hanks balanced salt solution (BSS, pH 7.4) supplemented with 2% bovine albumin were incubated with various concentrations of the drug (0.10-1.0 mM) at 37°C for 120 min. After incubation, the tumor cells in BSS were inoculated subcutaneously into the right flank of mice (10<SUP>6</SUP> cells/mouse). All mice given the tumor cells incubated alone developed solid tumor. However, no tumor growth was observed in groups of mice given the tumor cells pretreated with 0.3 or 1.0 mM pentazocine. The <I>in vivo</I> effect of pentazocine was then examined against Ehrlich ascites carcinoma in mice. Mice inoculated intraperitoneally with Ehrlich tumor cells in BSS (2×10<SUP>6</SUP> cells/mouse) were given various doses of pentazocine (20-80 mg/kg/day) intraperitoneally once a day for 5 successive days. The average survival time in a group of mice given the tumor cells alone was about 19 days, and the survival time was about 29 days in a group of animals, treated with pentazocine in a dose of 80 mg/kg/day (p<0.01).
- 社団法人 日本薬理学会の論文
著者
関連論文
- CHANGE IN THE CONTRACTILITY OF RAT ATRIAL MUSCLE BY COLD PRESERVATION
- PHARMACOLOGICAL CHARACTERIZATION OF α_1-ADRENOCEPTOR SUBTYPES IN RAT VAS DEFERENS
- α_1-ADRENOCEPTOR SUBCLASSIFICATION IN VASCULAR SMOOTH MUSCLE
- α_1-ADRENOCEPTOR SUBTYPES INVOLVED IN ADRENERGIC NEUROGENIC CONTRACTION IN DOG MESENTERIC, CAROTID AND RABBIT CAROTID ARTERIES
- EFFECT OF THE CENTRALLY ACTING ANTITUSSIVES ON ASCITES TUMOR CELLS
- EFFECT OF PENTAZOCINE ON EHRLICH ASCITES TUMOR CELLS
- IN VITRO ANTI-TUMOR ACTIVITY OF LIPID EXTRACTS FROM A GROUP A STREPTOCOCCUS AGAINST EHRLICH ASCITES CARCINOMA IN MICE
- EFFECT OF PENTAZOCINE AND RELATED COMPOUNDS ON THE LIPID COMPOSITION OF EHRLICH ASCITES TUMOR CELLS
- EFFECT OF STREPTOCOCCAL LIPIDS ON EHRLICH ASCITES TUMOR CELLS
- In Vitro Pharmacological Profile of the Novel .ALPHA.1-Adrenoceptor Antagonist HSR-175.
- Pharmacological profile of the novel .ALPHA.-adrenoceptor antagonist KT-611(naftopidil).
- DJ-7141, a new alpha-2 agonist with only a mild hypotensive action.
- Cytotoxicity of cortisone-resistant lymphocytes from mice treated with a group A streptococcus or freund's complete adjuvant against tumor cells.
- Subtypes of .ALPHA.1-Adrenoceptors Involved in Noradrenaline-Induced Contractions of Rat Thoracic Aorta and Dog Carotid Artery.
- Evidence for Sympathetic, Purinergic Transmission in the Iris Dilator Muscle of the Rabbit.
- Dissociation between sympathetic purinergic response and ATP response in the mesenteric artery of the dog.
- Copper-induced alteration of muscarinic binding in bovine adrenal medulla.
- Tetranitromethane modification of the muscarinic receptors in bovine adrenal medulla.
- Effect of Pentazocine on the Cytotoxicity of Cortisone-Resistant Lymphocytes from Mouse Thymus.
- Tizanidine May Discriminate between Imidazoline-Receptors and .ALPHA.2-Adrenoceptors.
- Lack of effects of carbachol on the Na-Ca exchange mechanism in frog atrial muscle treated with goniopora toxin.
- Selective interaction of DG-5128 with a low agonist affinity state of alpha-2 adrenoceptor.
- Effect of several d-morphinans on ascites tumors in mice.
- Effect of dextromethorphan and dimemorfan on the neutral lipids of tumor cells.